John Camm

Summary

Affiliation: St George's
Country: UK

Publications

  1. ncbi Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation
    Demosthenes Katritsis
    Department of Cardiology, Athens Euroclinic, Athens, Greece
    Am J Cardiol 102:330-4. 2008
  2. ncbi Managing anticoagulation for atrial fibrillation: current issues and future strategies
    A John Camm
    Division of Clinical Sciences, St George s University of London, London, UK
    J Intern Med 273:31-41. 2013
  3. ncbi A proposal for new clinical concepts in the management of atrial fibrillation
    A John Camm
    St George s, University of London, United Kingdom
    Am Heart J 164:292-302.e1. 2012
  4. ncbi Usefulness of continuous electrocardiographic monitoring for atrial fibrillation
    A John Camm
    St George s University of London, London, United Kingdom
    Am J Cardiol 110:270-6. 2012
  5. ncbi Atrial fibrillation: the rate versus rhythm management controversy
    A J Camm
    Division of Clinical Sciences, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    J R Coll Physicians Edinb 42:23-34. 2012
  6. ncbi Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits
    John Camm
    British Heart Foundation, St George s University of London, Department of Cardiological Sciences, London, United Kingdom
    Int J Cardiol 155:362-71. 2012
  7. ncbi Medical treatment of atrial fibrillation
    A John Camm
    St George s Hospital, London, UK
    J Cardiovasc Med (Hagerstown) 13:97-107. 2012
  8. ncbi Aubrey Leatham and the introduction of cardiac pacing to the UK
    A John Camm
    British Heart Foundation Professor of Clinical Cardiology, St George s Hospital and University of London, Cranmer Terrace, London SW17 0RE, UK
    Europace 12:1356-9. 2010
  9. ncbi Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis
    A John Camm
    Division of Cardiac and Vascular Sciences, St George s University of London, London, UK
    Clin Ther 32:426-36. 2010
  10. ncbi Rate control in the medical management of atrial fibrillation
    A J Camm
    Division of Cardiac and Vascular Sciences, St George's University of London, London, UK
    Heart 93:35-8. 2007

Detail Information

Publications101 found, 100 shown here

  1. ncbi Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation
    Demosthenes Katritsis
    Department of Cardiology, Athens Euroclinic, Athens, Greece
    Am J Cardiol 102:330-4. 2008
    ..0 to 6.6, p = 0.038). In conclusion, anatomically guided GP ablation is feasible and safe in the electrophysiology laboratory, but this approach yields inferior clinical results compared with circumferential ablation...
  2. ncbi Managing anticoagulation for atrial fibrillation: current issues and future strategies
    A John Camm
    Division of Clinical Sciences, St George s University of London, London, UK
    J Intern Med 273:31-41. 2013
    ..The role of conventional and new anticoagulant options will also be discussed...
  3. ncbi A proposal for new clinical concepts in the management of atrial fibrillation
    A John Camm
    St George s, University of London, United Kingdom
    Am Heart J 164:292-302.e1. 2012
    ..There is little consensus on optimal rate control and no information relating to optimum rate control in specific populations. This article highlights new concepts in AF and directions for future research...
  4. ncbi Usefulness of continuous electrocardiographic monitoring for atrial fibrillation
    A John Camm
    St George s University of London, London, United Kingdom
    Am J Cardiol 110:270-6. 2012
    ....
  5. ncbi Atrial fibrillation: the rate versus rhythm management controversy
    A J Camm
    Division of Clinical Sciences, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    J R Coll Physicians Edinb 42:23-34. 2012
    ..In the meantime the pendulum of clinical opinion has begun to swing towards a rhythm control strategy...
  6. ncbi Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits
    John Camm
    British Heart Foundation, St George s University of London, Department of Cardiological Sciences, London, United Kingdom
    Int J Cardiol 155:362-71. 2012
    ..Accumulating efficacy and safety data for new and emerging AADs holds promise for improved AF management and outcomes...
  7. ncbi Medical treatment of atrial fibrillation
    A John Camm
    St George s Hospital, London, UK
    J Cardiovasc Med (Hagerstown) 13:97-107. 2012
    ..This review provides a contemporary evidence-based insight into the medical management of atrial fibrillation in the modern era...
  8. ncbi Aubrey Leatham and the introduction of cardiac pacing to the UK
    A John Camm
    British Heart Foundation Professor of Clinical Cardiology, St George s Hospital and University of London, Cranmer Terrace, London SW17 0RE, UK
    Europace 12:1356-9. 2010
    ..The nickel-cadmium 'accumulator', which powered the pacemaker, had to be recharged once a week...
  9. ncbi Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis
    A John Camm
    Division of Cardiac and Vascular Sciences, St George s University of London, London, UK
    Clin Ther 32:426-36. 2010
    ....
  10. ncbi Rate control in the medical management of atrial fibrillation
    A J Camm
    Division of Cardiac and Vascular Sciences, St George's University of London, London, UK
    Heart 93:35-8. 2007
  11. ncbi Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat
    A John Camm
    St George's, University of London, London SW17 0RE
    BMJ 334:637. 2007
  12. ncbi Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study
    A J Camm
    St George s Hospital, London, UK
    Europace 9:1110-8. 2007
    ....
  13. ncbi New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant
    A John Camm
    Division of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, London, SW17 0RE, UK
    J Interv Card Electrophysiol 23:7-14. 2008
    ....
  14. ncbi Medical management of atrial fibrillation: state of the art
    John Camm
    Department of Cardiological Sciences, St George s Hospital Medical School, London, UK
    J Cardiovasc Electrophysiol 17:S2-6. 2006
    ....
  15. ncbi European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
    A John Camm
    Division of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, SW17 0RE London, UK
    Europace 12:1063-9. 2010
    ..It seems unlikely that adequate equity of access to this potentially lifesaving treatment will be provided until adequate registries, audits, and gap analyses are undertaken throughout Europe...
  16. ncbi The cost of implantable defibrillators: perceptions and reality
    John Camm
    St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    Eur Heart J 28:392-7. 2007
    ..Recent guidelines have recommended more wide-ranging indications for the use of implantable cardioverter defibrillator (ICD) therapy, yet even more restrained previous guidelines have not been implemented for a variety of reasons...
  17. ncbi A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation
    A John Camm
    St George s University of London, United Kingdom
    J Am Coll Cardiol 57:313-21. 2011
    ..This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF)...
  18. ncbi Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)
    A John Camm
    St George s University of London, Cranmer Terrace, London, United Kingdom
    J Am Coll Cardiol 58:493-501. 2011
    ..RECORDAF is the first worldwide, prospective, observational survey of management of atrial fibrillation (AF) in unselected, community-based patients...
  19. ncbi Edoxaban: a new oral direct factor xa inhibitor
    A John Camm
    Division of Clinical Sciences, St Georges University of London, UK
    Drugs 71:1503-26. 2011
    ....
  20. ncbi Atrial fibrillation and risk
    A John Camm
    St George s University of London, London, United Kingdom
    Clin Cardiol 35:S1-2. 2012
    ..He discloses no other direct conflicts of interest to the submitted work. Dr. Camm has served as a consultant, received grant funding, and has been a member of the speakers bureau for Sanofi Aventis...
  21. ncbi Safety considerations in the pharmacological management of atrial fibrillation
    A John Camm
    Department of Cardiological Sciences, St George s University of London, Cranmer Terrace, London SW17 0RE, United Kingdom
    Int J Cardiol 127:299-306. 2008
    ..Notwithstanding these considerations, most patients with AF can be considered for rhythm control, provided there is adequate pre-treatment assessment and protocols for initiation, dosing and monitoring are followed with care...
  22. ncbi Impaired right ventricular systolic function demonstrated by reduced atrioventricular plane displacement in adults with Marfan syndrome
    Anatoli Kiotsekoglou
    Department of Cardiac and Vascular Sciences, St George s, University of London, Cranmer Terrace, London SW17 0RE, UK
    Eur J Echocardiogr 10:295-302. 2009
    ..Mild LV dysfunction has been demonstrated in Marfan syndrome (MFS). However, little attention has been paid to the functioning of the RV. The aim of this study was to assess RV function in unoperated adult MFS patients...
  23. ncbi Impaired biventricular deformation in Marfan syndrome: a strain and strain rate study in adult unoperated patients
    Anatoli Kiotsekoglou
    Department of Cardiac and Vascular Sciences, St George s University of London, London, UK
    Echocardiography 28:416-30. 2011
    ..To investigate the presence of any regional myocardial deformation abnormalities in Marfan syndrome (MFS) and determine the benefits of using advanced echocardiography compared to conventional techniques...
  24. ncbi Assessment of aortic stiffness in marfan syndrome using two-dimensional and Doppler echocardiography
    Anatoli Kiotsekoglou
    Department of Cardiac and Vascular Sciences, St George s University of London, London, UK
    Echocardiography 28:29-37. 2011
    ..Pulsed-wave velocity (PWV) constitutes the best indirect AoS measurement. We aimed to assess PWV in MFS patients using two-dimensional (2D) and Doppler echocardiography...
  25. ncbi Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial
    Antonios Kourliouros
    Department of Cardiothoracic Surgery, St George s Hospital, London, United Kingdom
    J Thorac Cardiovasc Surg 141:244-8. 2011
    ....
  26. ncbi Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome
    Anatoli Kiotsekoglou
    Department of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    Eur J Echocardiogr 10:947-55. 2009
    ..We aimed to investigate whether, in the absence of significant valvular disease, diastolic dysfunction is present not only in both ventricles but also in the atrial cavities...
  27. ncbi Effect of aortic stiffness on left ventricular long-axis systolic function in adults with Marfan syndrome
    Anatoli Kiotsekoglou
    St George s, University of London, Department of Cardiac and Vascular Sciences, London, UK
    Hellenic J Cardiol 51:501-11. 2010
    ..Recent studies have also shown primary myocardial impairment in MFS. We investigated whether left ventricular (LV) function could be further impaired when acting against a stiff vascular system...
  28. ncbi Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome
    Anatoli Kiotsekoglou
    Department of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    Eur J Echocardiogr 9:605-13. 2008
    ..This study aimed to ascertain LV functional abnormalities in MFS patients using M-mode and tissue Doppler imaging (TDI)...
  29. ncbi Current concepts in the pathogenesis of atrial fibrillation
    Antonios Kourliouros
    Department of Cardiac Surgery, St George s University of London, United Kingdom
    Am Heart J 157:243-52. 2009
    ..In addition, the interrelation between different mechanisms responsible for AF will be demonstrated, providing further insight into the complex pathophysiology...
  30. ncbi Current strategies in the management of atrial fibrillation
    Marjan Jahangiri
    Department of Cardiac Surgery, St George s Hospital Medical School, London, United Kingdom
    Ann Thorac Surg 82:357-64. 2006
    ..Furthermore, in most series it is difficult to distinguish results of surgery for lone AF and AF associated with valvular heart disease and coronary artery disease...
  31. ncbi Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
    Irina Savelieva
    Division of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    Europace 10:647-65. 2008
    ..However, despite exciting results from animal experiments and promising outcomes from retrospective analyses, there is no robust evidence of specific effects of these drugs to transform current clinical practice...
  32. ncbi Update on atrial fibrillation: part I
    Irina Savelieva
    St George s University of London, Cranmer Terrace, London, U K
    Clin Cardiol 31:55-62. 2008
    ....
  33. ncbi Dose-related effect of statins on atrial fibrillation after cardiac surgery
    Antonios Kourliouros
    Department of Cardiothoracic Surgery, St George s Hospital, London, United Kingdom
    Ann Thorac Surg 85:1515-20. 2008
    ..It increases morbidity and prolongs hospital stay. A role for statins in the prevention of AF has been suggested. We hypothesized that the incidence of postoperative AF due to statin therapy is dose-related...
  34. ncbi T-wave alternans and left ventricular wall thickness in predicting arrhythmic risk in patients with hypertrophic cardiomyopathy
    Valentina Otja Puntmann
    St George s, University of London, London, UK
    Circ J 74:1197-204. 2010
    ..The aim of the present study was to investigate the relationship between LV wall thickness (LVWT) and microvolt T-wave alternans (TWA), a surrogate risk marker of ventricular tachyarrhythmias (VTAs)...
  35. ncbi Statins and polyunsaturated fatty acids for treatment of atrial fibrillation
    Irina Savelieva
    Division of Cardiac and Vascular Sciences, St George s University of London, London, UK
    Nat Clin Pract Cardiovasc Med 5:30-41. 2008
    ..This Review provides a contemporary evidence-based insight into the possible preventive and reverse remodeling roles of statins and polyunsaturated fatty acids in AF...
  36. ncbi Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
    Irene Savelieva
    Division of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, London, SW17 0RE, UK
    Naunyn Schmiedebergs Arch Pharmacol 381:1-13. 2010
    ..This review provides a contemporary evidence-based insight into the possible preventative and reverse remodeling role of statins and polyunsaturated fatty acids in AF...
  37. ncbi Update on atrial fibrillation: part II
    Irina Savelieva
    St George s University of London, London, UK
    Clin Cardiol 31:102-8. 2008
    ....
  38. ncbi Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials
    Yee Guan Yap
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
    Eur Heart J 26:1385-93. 2005
    ..However, contemporary data on such information is lacking...
  39. ncbi Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
    Boaz Mendzelevski
    CoreLab Partners Inc, London, UK
    Br J Clin Pharmacol 73:203-9. 2012
    ..To assess steady-state effects of therapeutic and supra-therapeutic doses of prucalopride on the QT interval using a novel design involving a parallel placebo group with nested crossover for positive control...
  40. ncbi Atrial fibrillation--all change!
    Irina Savelieva
    St George's University of London, London
    Clin Med 7:374-9. 2007
  41. ncbi Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome
    Malini Govindan
    Division of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, London, UK
    Heart 96:1904-8. 2010
    ..The authors sought to assess the value of the high right precordial leads (RPL) to detect the Type I Brugada ECG pattern in patients suspected of carrying Brugada syndrome (BrS)...
  42. ncbi Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
    Kim Fox
    Department of Cardiology, Royal Brompton Hospital, London, UK
    Eur Heart J 27:1341-81. 2006
  43. ncbi Assessment of carotid compliance using real time vascular ultrasound image analysis in Marfan syndrome
    Anatoli Kiotsekoglou
    Department of Cardiac and Vascular Sciences, St George s, University of London, Cranmer Terrace, London, UK
    Echocardiography 26:441-51. 2009
    ..We sought to detect any alterations in CC using the vascular image analysis system (VIA)...
  44. ncbi Predictive characteristics of holter-based postinfarction risk stratifiers appear superior to electrophysiological testing
    Dan Wichterle
    Department of Cardiac and Vascular Sciences, St George s Hospital Medical School, London, UK
    Pacing Clin Electrophysiol 28:S182-6. 2005
    ..0% and 46.5% and PPV of 37.4% and 18.7%. Compared with the noninvasive Holter-based CRS, invasive PVS appears inferior in the identification of high-risk post-MI patients with left ventricular dysfunction...
  45. ncbi 'Atrial fibrillation--an end to the epidemic?'
    John Camm
    Division of Cardiac and Vascular Sciences, St George s Hospital, London
    Circulation 112:iii. 2005
  46. ncbi Atrial fibrillation and heart failure: natural history and pharmacological treatment
    Irina Savelieva
    Department of Cardiac and Vascular Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, United Kingdom
    Europace 5:S5-19. 2004
    ....
  47. ncbi Conduction patterns in the cardiac veins: electrophysiologic characteristics of the connections between left atrial and coronary sinus musculature
    Demosthenes G Katritsis
    Department of Cardiology, Athens Euroclinic, Athens, Greece
    J Interv Card Electrophysiol 10:51-8. 2004
    ..The pattern of circumferential activation in the CS has not been investigated. Furthermore, no data exist on conduction characteristics within the great cardiac vein (GCV) or the middle cardiac vein (MCV)...
  48. ncbi Treatment of atrial fibrillation with an implantable atrial defibrillator--long term results
    J Christoph Geller
    University Hospitals of Magdeburg, Magdeburg, Germany
    Eur Heart J 24:2083-9. 2003
    ..To evaluate the long-term outcome with an implantable atrial defibrillator (IAD) in patients with recurrent atrial fibrillation (AF)...
  49. ncbi Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification
    A John Camm
    Department of Cardiology, St George s Hospital, London, UK
    Circulation 109:990-6. 2004
    ..Azimilide, a novel class III antiarrhythmic drug, was investigated for its effects on mortality in patients with depressed LVF after recent MI and in a subpopulation of patients with low HRV...
  50. ncbi Rhythm control versus rate control for atrial fibrillation and heart failure
    Denis Roy
    Montreal Heart Institute and the Université de Montréal, Montreal, QC H1T 1C8, Canada
    N Engl J Med 358:2667-77. 2008
    ..However, the benefits and risks of this approach have not been adequately studied...
  51. ncbi The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial
    Craig M Pratt
    The Methodist DeBakey Heart Center and Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Am Coll Cardiol 43:1211-6. 2004
    ....
  52. ncbi Prolongation of the QT interval and ventricular arrhythmias: some early observations
    Velislav N Batchvarov
    Division of Cardiac and Vascular Sciences, St. George's University of London, London, United Kingdom
    Heart Rhythm 5:892-4. 2008
  53. ncbi Paradoxical autonomic modulation of atrioventricular nodal conduction during heart rate turbulence
    Dan Wichterle
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, SW17 0RE London, United Kingdom
    Pacing Clin Electrophysiol 26:440-3. 2003
    ..Dynamics of AV delay has little impact on the accuracy of HRT assessment from surface ECG. The significant temporal dissociation of R-R and AV interval dynamics after a VPB remains unexplained...
  54. ncbi Drug induced QT prolongation and torsades de pointes
    Yee Guan Yap
    Department of Cardiological Sciences, St George's Hospital Medical School, London, UK
    Heart 89:1363-72. 2003
  55. ncbi Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion
    Mark M Gallagher
    Department of Cardiological Sciences, St George s Hospital Medical School, London, United Kingdom
    J Am Coll Cardiol 40:926-33. 2002
    ..The goal of this study was to identify the factors responsible for embolic complications of direct current (DC) cardioversion of atrial arrhythmias...
  56. ncbi Rate versus rhythm control: is the debate over?
    A John Camm
    Department of Cardiological Sciences, St George s Hospital Medical School, London, UK
    J Interv Card Electrophysiol 7:7-11. 2002
  57. ncbi Atrial pacing for the prevention and termination of atrial fibrillation
    Irina Savelieva
    St. Georges Hospital Medical School, London SW17 0RE, United Kingdom
    Am J Geriatr Cardiol 11:380-98. 2002
    ..The evolution of hybrid therapy, in which two or more different strategies are employed in the same patient, may be the most effective approach to management of AF...
  58. ncbi Prognostic significance of serial P wave signal-averaged electrocardiograms following external electrical cardioversion for persistent atrial fibrillation: a prospective study
    Xiao Hua Guo
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, U K
    Pacing Clin Electrophysiol 26:299-304. 2003
    ..0028) and created a significant difference between the two slopes (P = 0.0004). The evolution of P-SAECG parameters after ECV differs in patients whose AF recurs versus patients who remain in SR...
  59. ncbi Heart rate turbulence after atrial and ventricular premature beats: relation to left ventricular function and coupling intervals
    Irina Savelieva
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, London, SW17 0RE, United Kingdom
    Pacing Clin Electrophysiol 26:401-5. 2003
    ..Heart rate turbulence (HRT) represents a biphasic chronotropic response of the sinus node to a single ventricular premature beat (VPB)...
  60. ncbi Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?
    A John Camm
    St George s Hospital Medical School, London, United Kingdom
    Heart Rhythm 1:244-6. 2004
  61. ncbi 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?
    Shamil Yusuf
    Department of Cardiovascular Medicine, St Georges Hospital Medical School, London, United Kingdom
    J Cardiovasc Electrophysiol 14:209-14. 2003
    ..It also delves into the potential benefits and limitations of 5-HT4 antagonists in the prevention and management of this arrhythmia...
  62. ncbi The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough?
    Irina Savelieva
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, London SW1 0RE, United Kingdom
    J Interv Card Electrophysiol 8:103-15. 2003
    ..Dual chamber cardioverter-defibrillators with capacity to prevent and interrupt AF may offer more comprehensive and successful treatment for patients with advanced heart disease, frequent paroxysms of AF, and the risk of proarrhythmia...
  63. ncbi ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology
    Carina Blomstrom-Lundqvist
    Circulation 108:1871-909. 2003
  64. ncbi Translation of clinical trials into clinical practice: use of results in formulating guidelines
    A John Camm
    Department of Cardiological Sciences, St George s Hospital Medical School, London, United Kingdom
    J Cardiovasc Electrophysiol 14:S9-14. 2003
    ..Arrhythmology guidelines now must be funded, implemented, value tested, and regularly revised...
  65. ncbi ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology
    Carina Blomstrom-Lundqvist
    J Am Coll Cardiol 42:1493-531. 2003
  66. ncbi Rationale and patient selection for "hybrid" drug and device therapy in atrial and ventricular arrhythmias
    A John Camm
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
    J Interv Card Electrophysiol 9:207-14. 2003
    ..Despite the lack of formal studies there is a very substantial clinical experience which testifies to the value of hybrid therapy for the management of both atrial fibrillation and ventricular tachycardia/fibrillation...
  67. ncbi Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation
    Demosthenes G Katritsis
    Department of Cardiology, Athens Euroclinic, Athens, Greece
    Am J Cardiol 92:1116-9. 2003
    ..86) lower risk of relapse of AF compared with patients in the bisoprolol group, although results were statistically insignificant (p = 0.661) after controlling for patient age, gender, baseline heart rate, and left atrial diameter...
  68. ncbi Clinical outcome of left atrial ablation for paroxysmal atrial fibrillation is related to the extent of radiofrequency ablation
    Demosthenes Katritsis
    Department of Cardiology, Athens Euroclinic, 9 Athanassiadou Street, Athens 11521, Greece
    J Interv Card Electrophysiol 22:31-7. 2008
    ..We investigated whether the extent of atrial damage conferred by radiofrequency lesions is a predictor of success after ablation, regardless of the method employed for ablation...
  69. ncbi Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, P Debyelaan 25, PO Box 5800, Maastricht 6221AZ, The Netherlands
    Eur Heart J 29:915-22. 2008
    ..To assess the relation between the atrial fibrillation (AF) subtype and thrombo-embolic events...
  70. ncbi Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation
    Marek Malik
    Section of Noninvasive Electrophysiology, Department of Cardiac and Vascular Sciences, St George s Hospital Medical School, London
    Pacing Clin Electrophysiol 27:1659-69. 2004
    ..g., three complexes in one lead only)...
  71. ncbi ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Societ
    Douglas P Zipes
    Eur Heart J 27:2099-140. 2006
  72. ncbi ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice
    Valentin Fuster
    Circulation 114:e257-354. 2006
  73. ncbi ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Comm
    Valentin Fuster
    J Am Coll Cardiol 48:854-906. 2006
  74. ncbi Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database
    Craig M Pratt
    Department of Cardiology, Methodist DeBakey Heart Center, Houston, Texas 77030, USA
    J Am Coll Cardiol 48:471-7. 2006
    ..The purpose of this study was to assess the incidence, temporal characteristics, and risk factors associated with azimilide-associated torsades de pointes (TdP) ventricular tachycardia...
  75. ncbi Delayed paced ventricular activation in the long QT syndrome is associated with ventricular fibrillation
    Richard C Saumarez
    Department of Cardiology, Papworth Hospital, Cambridge, United Kingdom
    Heart Rhythm 3:771-8. 2006
    ..LQTS may cause sudden cardiac death (SCD), but the mechanisms linking gene mutations to ventricular fibrillation (VF) are unclear...
  76. ncbi Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data
    Jeffrey S Healey
    Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada, L8L 2X2
    Circulation 114:11-7. 2006
    ..No trial has shown a mortality reduction, and only 1 small trial suggested a reduction in stroke. The goal of this review was to determine whether atrial-based pacing prevents major cardiovascular events...
  77. ncbi Effect of slow pathway ablation in atrioventricular nodal reentrant tachycardia on the electrophysiologic characteristics of the inferior atrial inputs to the human atrioventricular node
    Demosthenes G Katritsis
    Department of Cardiology, Athens Euroclinic, Greece
    Am J Cardiol 97:860-5. 2006
    ....
  78. ncbi Pacemaker selection: time for a rethinking of complex pacing systems
    John Silberbauer
    Eur Heart J 27:1126-7; author reply 1127. 2006
  79. ncbi Turbulence dynamics: an independent predictor of late mortality after acute myocardial infarction
    Axel Bauer
    , Ismaninger Strasse 22, , Germany
    Int J Cardiol 107:42-7. 2006
    ..The results indicate that in addition to the overall level of autonomic function the loss of autonomic adaptability contributes to prognosis...
  80. ncbi Clinical trial design to evaluate the effects of drugs on cardiac repolarization: current state of the art
    A John Camm
    St George s Hospital Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK
    Heart Rhythm 2:S23-9. 2005
    ....
  81. ncbi Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, P Debyelaan 25, PO Box 5800, Maastricht 6202AZ, Maastricht, The Netherlands
    Eur Heart J 26:2422-34. 2005
    ..To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines...
  82. ncbi ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com
    Douglas P Zipes
    J Am Coll Cardiol 48:e247-346. 2006
  83. ncbi Right and left inferior extensions of the atrioventricular node may represent the anatomic substrate of the slow pathway in humans
    Demosthenes G Katritsis
    Department of Cardiology, Athens Euroclinic, Greece
    Heart Rhythm 1:582-6. 2004
    ..The purpose of this study was to investigate the electrophysiologic characteristics of the inferior extensions of the human atrioventricular (AV) node and their possible relationship to slow pathway conduction...
  84. ncbi Post-extrasystolic changes of the T wave in a patient with congestive heart failure
    Velislav N Batchvarov
    Division of Cardiac and Vascular Sciences, St George's University of London, Cranmer Terrace, London SW17 0RE, UK
    Europace 9:1093. 2007
  85. ncbi Recurrence of left atrium-pulmonary vein conduction following successful disconnection in asymptomatic patients
    Demosthenes Katritsis
    Department of Cardiology, Athens Euroclinic, 9 Athanassiadou Street, Athens 11521, Greece
    Europace 6:425-32. 2004
    ..The clinical significance of conduction recurrences in isolated pulmonary veins of patients with atrial fibrillation is not established...
  86. ncbi ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee fo
    Valentin Fuster
    France
    Europace 8:651-745. 2006
  87. ncbi Association of Met439Thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum HSP70 protein levels
    Ali R Afzal
    Department of Clinical Developmental Sciences, St George s University of London, London, UK
    Cardiology 110:45-52. 2008
    ..Previously, we have shown that higher expression of heat shock protein (HSP) 70 was associated with decreased incidence of postoperative AF (PoAF), suggestive of an antiarrhythmic role...
  88. ncbi Incorrect electrode cable connection during electrocardiographic recording
    Velislav N Batchvarov
    Division of Cardiac and Vascular Sciences, St George s University of London, Cranmer Terrace, Tooting, London SW17 0RE, UK
    Europace 9:1081-90. 2007
    ..Computerized algorithms for detection of lead misplacement, such as those based on artificial neural networks, or on correlation between original and reconstructed leads, have been developed...
  89. ncbi Catheter ablation of atrial fibrillation: do we know what we are doing?
    Demosthenes G Katritsis
    Europace 9:1002-5. 2007
  90. ncbi Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices
    Irina Savelieva
    St George s University of London, London, United Kingdom
    Ann Med 39:371-91. 2007
    ....
  91. ncbi Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Am Heart J 153:1006-12. 2007
    ..What consequences does guideline-deviant antithrombotic treatment have in daily practice?..
  92. ncbi Arrhythmic complications of electrical cardioversion: relationship to shock energy
    Mark M Gallagher
    Department of Cardiological Sciences, St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
    Int J Cardiol 123:307-12. 2008
    ..We hypothesised that more powerful shocks would exceed the upper limit of vulnerability for inducing ventricular fibrillation. The initial use of higher energy could therefore reduce arrhythmic complications...
  93. ncbi Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction
    Dan Wichterle
    Department of Cardiological Sciences, St George's Hospital Medical School, London, UK
    Circulation 110:1183-90. 2004
    ..02), respectively. CONCLUSIONS: An innovative analysis of frequency-domain HRV, which characterizes the distribution of spectral power within the low-frequency band, is a potent and independent risk stratifier in postinfarction patients...
  94. ncbi Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction
    Yee Guan Yap
    Department of Cardiological Sciences, St George s Hospital Medical School, London, UK
    Heart 93:832-6. 2007
    ..The selection of patients for prophylactic implantable cardioverter-defibrilator (ICD) treatment after myocardial infarction (MI) remains controversial...
  95. ncbi [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]
    Douglas P Zipes
    Rev Esp Cardiol 59:1328. 2006
  96. ncbi Atrial fibrillation and the urologist
    Khurshid R Ghani
    Department of Urology, St George's Hospital, London, UK
    BJU Int 94:254-5. 2004
  97. ncbi Catheter ablation of atrial fibrillation
    Fu Siong Ng
    Department of Cardiological Sciences, St. George's Hospital Medical School, London, UK
    Clin Cardiol 25:384-94. 2002
    ..Although still at an early stage of development, preliminary results using focal ablation and circumferential ablation show extreme promise...
  98. ncbi Sex differences in repolarization homogeneity and its circadian pattern
    Peter Smetana
    Department of Cardiological Sciences, St. George's Hospital Medical School, London SW17 0RE, United Kingdom
    Am J Physiol Heart Circ Physiol 282:H1889-97. 2002
    ..A sex difference was also observed for HR and QTc interval; however, the circadian patterns of the repolarization homogeneity descriptors were different from those of HR and QTc intervals...
  99. ncbi Ablation for atrial fibrillation
    A John Camm
    Nat Clin Pract Cardiovasc Med 3:345. 2006
  100. ncbi Prognostic value of heterogeneity of ventricular repolarization in survivors of acute myocardial infarction
    Velislav N Batchvarov
    Department of Cardiac and Vascular Sciences, St George s Hospital Medical School, London, England
    Clin Cardiol 27:653-9. 2004
    ....
  101. ncbi Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy)
    Azad Ghuran
    Department of Cardiological and Public Health Sciences, St. George's Hospital Medical School, London, United Kingdom
    Am J Cardiol 89:184-90. 2002
    ..By combining HR turbulence, BRS, and SDNN, a comprehensive assessment of cardiac autonomic reflexes and modulation can be obtained...